Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

Cardiorenal protective effects of canagliflozin in CREDENCE according to glucose lowering

Introduction Relationships between glycemic-lowering effects of sodium glucose co-transporter 2 inhibitors and impact on kidney and cardiovascular outcomes are uncertain.Research design and methods We analyzed 4395 individuals with prebaseline and postbaseline hemoglobin A1c (HbA1c) randomized to ca...

Full description

Bibliographic Details
Main Authors: Bernard Zinman, Bruce Neal, George L Bakris, Vlado Perkovic, Meg J Jardine, Kris Rogers, Jie Yu, Adeera Levin, Dick de Zeeuw, Hong Zhang, Kenneth W Mahaffey, Clare Arnott, Rajiv Agarwal, Gian Luca Di Tanna, Carol Pollock, David C Wheeler, Christopher P Cannon, David M Charytan, Hiddo J Lambers Heerspink, Norman Rosenthal
Format: Article
Language:English
Published: BMJ Publishing Group 2023-05-01
Series:BMJ Open Diabetes Research & Care
Online Access:https://drc.bmj.com/content/11/3/e003270.full

Internet

https://drc.bmj.com/content/11/3/e003270.full

Similar Items